Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,774 | -38,371 | -44,434 | -91,564 | -52,006 |
| Depreciation Amortization | 2,572 | 4,089 | 4,138 | 6,201 | 11,090 |
| Accounts payable and accrued liabilities | -4,745 | 2,223 | 1,895 | 63 | -14,671 |
| Other Working Capital | -12,731 | 2,763 | 2,311 | -440 | -24,556 |
| Other Operating Activity | 12,908 | -10,034 | 17,617 | 69,898 | 25,615 |
| Operating Cash Flow | $-26,770 | $-39,330 | $-18,473 | $-15,842 | $-54,528 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,210 | 23,349 | 14,019 | -54,534 | N/A |
| PPE Investments | -2 | -13 | -62 | -61 | -11 |
| Investing Cash Flow | $18,208 | $23,336 | $13,957 | $-54,595 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 744 |
| Debt Repayment | N/A | N/A | -2,251 | -6,516 | -6,233 |
| Common Stock Issued | 26,691 | 1,034 | 433 | 89,643 | 24,926 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 45,038 |
| Financing Cash Flow | $26,691 | $1,034 | $-1,818 | $83,127 | $64,475 |
| Exchange Rate Effect | -75 | -61 | -50 | 4 | -11 |
| Beginning Cash Position | 6,105 | 21,126 | 27,510 | 14,816 | 4,891 |
| End Cash Position | 24,159 | 6,105 | 21,126 | 27,510 | 14,816 |
| Net Cash Flow | $18,054 | $-15,021 | $-6,384 | $12,694 | $9,925 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,770 | -39,330 | -18,473 | -15,842 | -54,528 |
| Capital Expenditure | -2 | -13 | -62 | -61 | -11 |
| Free Cash Flow | -26,772 | -39,343 | -18,535 | -15,903 | -54,539 |